HUP2000379A1 - Favipiravir tartalmú gyógyszerkészítmény, ennek elõállítása és alkalmazása - Google Patents
Favipiravir tartalmú gyógyszerkészítmény, ennek elõállítása és alkalmazásaInfo
- Publication number
- HUP2000379A1 HUP2000379A1 HU2000379A HUP2000379A HUP2000379A1 HU P2000379 A1 HUP2000379 A1 HU P2000379A1 HU 2000379 A HU2000379 A HU 2000379A HU P2000379 A HUP2000379 A HU P2000379A HU P2000379 A1 HUP2000379 A1 HU P2000379A1
- Authority
- HU
- Hungary
- Prior art keywords
- favipiravir
- production
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- ZCGNOVWYSGBHAU-UHFFFAOYSA-N favipiravir Chemical compound NC(=O)C1=NC(F)=CNC1=O ZCGNOVWYSGBHAU-UHFFFAOYSA-N 0.000 title 1
- 229950008454 favipiravir Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2000379A HUP2000379A1 (hu) | 2020-11-17 | 2020-11-17 | Favipiravir tartalmú gyógyszerkészítmény, ennek elõállítása és alkalmazása |
PCT/HU2021/050062 WO2022106859A1 (en) | 2020-11-17 | 2021-11-17 | Pharmaceutical preparation containing favipiravir, its production and use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU2000379A HUP2000379A1 (hu) | 2020-11-17 | 2020-11-17 | Favipiravir tartalmú gyógyszerkészítmény, ennek elõállítása és alkalmazása |
Publications (1)
Publication Number | Publication Date |
---|---|
HUP2000379A1 true HUP2000379A1 (hu) | 2022-05-28 |
Family
ID=89993232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU2000379A HUP2000379A1 (hu) | 2020-11-17 | 2020-11-17 | Favipiravir tartalmú gyógyszerkészítmény, ennek elõállítása és alkalmazása |
Country Status (2)
Country | Link |
---|---|
HU (1) | HUP2000379A1 (hu) |
WO (1) | WO2022106859A1 (hu) |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK2407166T3 (da) * | 2009-03-13 | 2013-10-07 | Toyama Chemical Co Ltd | Tablet og granuleret pulver indeholdende 6-fluor-3-hydroxy-2-pyrazin-carboxamid |
JP7163014B2 (ja) * | 2016-10-31 | 2022-10-31 | エスエス製薬株式会社 | 感冒薬 |
RU2731932C1 (ru) * | 2020-05-07 | 2020-09-09 | Общество с ограниченной ответственностью "Кромис" (ООО "Кромис") | Противо-COVID-19 (SARS-CoV-2) вирусная фармацевтическая композиция |
-
2020
- 2020-11-17 HU HU2000379A patent/HUP2000379A1/hu unknown
-
2021
- 2021-11-17 WO PCT/HU2021/050062 patent/WO2022106859A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2022106859A1 (en) | 2022-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB202019241D0 (en) | Pharmaceutical composition | |
IL311331A (en) | Pharmaceutical preparation and its use | |
EP4183391A4 (en) | PHARMACEUTICAL COMPOSITION AND USE THEREOF | |
EP4223759A4 (en) | PYRAZOLOPYRIDAZINONE COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING IT AND ITS USE | |
IL312874A (en) | Pharmaceutical preparation and its use | |
EP4071170A4 (en) | PHARMACEUTICAL COMPOSITION, ITS PREPARATION METHOD AND ITS USE | |
EP3950677A4 (en) | QUINOLYL CONTAINING COMPOUND AND PHARMACEUTICAL COMPOSITION AND THEIR USE | |
GB2568928B (en) | Neuroprotective composition, preparation process thereof and medical uses thereof | |
HUP2000379A1 (hu) | Favipiravir tartalmú gyógyszerkészítmény, ennek elõállítása és alkalmazása | |
IL284132A (en) | A pharmaceutical compound, a method for its preparation and its use as a medicinal substance | |
EP3733176A4 (en) | COMPOSITION CONSISTING OF PIPERACILLIN, ITS PHARMACEUTICAL PREPARATION AND ITS USE | |
EP3718543A4 (en) | PHARMACEUTICAL COMPOSITION AND ITS USE | |
GB202004832D0 (en) | Therapeutic agaents, pharmaceutical compositions, and associated biomarkers | |
HUP2200422A1 (hu) | Tarlóbontó mikrobiológiai készítmény, ennek elõállítása és alkalmazása | |
GB202117015D0 (en) | New pharmaceutical composition | |
GB202117007D0 (en) | New pharmaceutical composition | |
GB202117005D0 (en) | New pharmaceutical composition | |
EP4139275A4 (en) | COMPOUNDS AND PHARMACEUTICAL USES THEREOF | |
GB202018901D0 (en) | New pharmaceutical composition | |
GB202009905D0 (en) | New pharmaceutical composition | |
GB202007328D0 (en) | New pharmaceutical composition | |
GB202007306D0 (en) | New pharmaceutical composition | |
EP4125873A4 (en) | PHARMACEUTICAL COMPOSITIONS AND USE THEREOF | |
GB202113078D0 (en) | New pharmaceutical use | |
EP4108236A4 (en) | PHARMACEUTICAL OLAPARIB COMPOSITION, MANUFACTURE THEREOF, MANUFACTURING METHOD THEREOF AND USE THEREOF |